Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts



Related Series

US Acute Care EHR Market Share 2024
US Hospital EMR Market Share 2023
US Hospital Market Share 2022
US Hospital Market Share 2021
US Hospital EMR Market Share 2020
US Hospital EMR Market Share 2019
US Hospital EMR Market Share 2018
US Hospital EMR Market Share 2017
2016 Hospital EMR Market Share
Acute EMR Market Share
Clinical Market Share 2014
Clinical Market Share 2013
Clinical Market Share 2012
Clinical Market Share 2011
Clinical Market Share 2008
Clinical Market Share 2007
Clinical Market Share Report 2006

Related Articles

 End chart zoom
CIS Purchase Decisions CIS Purchase Decisions
* A page refresh may be necessary to see the updated image

CIS Purchase Decisions
Riding the ARRA Wave

September 2, 2010

The incentives created for healthcare providers in the American Reinvestment and Recovery Act (ARRA) helped clinical information system (CIS) vendors have a big year overall in 2009. In acute care hospitals with 200 beds or more, nearly twice as many new systems were sold in 2009 than were sold in 2008. But this wave of new sales is affecting each vendor differently. Those who anticipated the wave are enjoying an extra boost, while those that didn’t see it coming are now trying to keep their heads above water. How is each vendor faring in the new market? By independently validating vendor-claimed wins, KLAS investigated which vendors are riding the ARRA wave and which are floundering in its wake.

author - Robert Ellis
Project Manager
Robert Ellis
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.